9 results on '"Jain, Michael D"'
Search Results
2. The CAR‐HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL
3. Imagining the cell therapist: Future CAR T cell monitoring and intervention strategies to improve patient outcomes
4. Transverse myelitis after anti‐CD19 directed CAR T cell therapy for relapsed large B cell lymphoma
5. Quality of life in caregivers of patients receiving chimeric antigen receptor T‐cell therapy
6. Acute patient‐reported outcomes in B‐cell malignancies treated with axicabtagene ciloleucel
7. Failure of rituximab is associated with a poor outcome in diffuse large B cell lymphoma‐type post‐transplant lymphoproliferative disorder
8. Haemophagocytic lymphohistiocytosis has variable time to onset following CD19 chimeric antigen receptor T cell therapy
9. Obinutuzumab as bridging therapy for successful manufacturing of axicabtagene ciloleucel for transformed follicular lymphoma with circulating cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.